Article
In-vivo Protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice
medRxiv · 2021 · Narayanappa, A.; Engler-Chiurazzi, E. B.; Murray-Brown, I. C.; Gressett, T. E.; Biose, I. J.; Chastain, W. H.; Bix, G.
Key facts
| Title | In-vivo Protection from SARS-CoV-2 infection by ATN-161 in k18-hACE2 transgenic mice |
|---|---|
| First author | Narayanappa, A.; Engler-Chiurazzi, E. B.; Murray-Brown, I. C.; Gressett, T. E.; Biose, I. J.; Chastain, W. H.; Bix, G. |
| Journal | medRxiv |
| Published | May 13, 2021 |
| DOI | 10.1101/2021.05.08.443275 |
| Devices mentioned | BK110039, K103302, K123955, K241806 |
| Product codes mentioned | JJH, NJT, OOI, QOF, NDS, PCA |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1